Nathalie Texier

Eric Van Ganse2
Stéphane Schuck1
Nicolas Roche1
Delphine Vial1
2Eric Van Ganse
1Stéphane Schuck
1Nicolas Roche
1Delphine Vial
Learn More
  • Nicolas Roche, Céline Pribil, Eric Van Ganse, Philippe Serrier, Bruno Housset, Déborah Poirier +3 others
  • 2014
BACKGROUND In Europe, administration of an inhaled corticosteroid (ICS) combined with a long-acting β2 agonist is approved in chronic obstructive pulmonary disease (COPD) patients with a pre-bronchodilator FEV1 < 60% predicted normal, a history of repeated exacerbations, and who have significant symptoms despite regular bronchodilator therapy. Minimal data(More)
BACKGROUND AND OBJECTIVES Suspected adverse drug reactions (ADR) reported by patients through social media can be a complementary tool to already existing ADRs signal detection processes. However, several studies have shown that the quality of medical information published online varies drastically whatever the health topic addressed. The aim of this study(More)
  • 1